[Federal Register Volume 67, Number 119 (Thursday, June 20, 2002)]
[Notices]
[Page 42023]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-15542]



[[Page 42023]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Availability of Government-Owned Inventions for Licensing

AGENCY: Centers for Disease Control and Prevention, Department of 
Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The inventions named in this notice are owned by agencies of 
the United States Government and are available for licensing in the 
United States (U.S.), In accordance with 35 U.S.C. 207, to achieve 
expeditious commercialization of results of federally funded research 
and development. Foreign patent applications are filed on selected 
inventions to extend market coverage for U.S. companies and may also be 
available for licensing.

ADDRESSES: Licensing information and copies of the U.S. patent 
applications listed below may be obtained by writing to Thomas E. 
O'Toole, M.P.H., Deputy Director, Technology Transfer Office, Centers 
for Disease Control and Prevention (CDC), Mailstop K-79, 1600 Clifton 
Road, Atlanta, GA 30333, telephone (770) 488-8611; facsimile (770) 488-
8615; or email [email protected]. A signed Confidential Disclosure Agreement 
will be required to receive copies of unpublished patent applications.

A Candidate DNA Vaccine Expressing West Nile Premembrane and Envelope 
Proteins Protects Mouse and Horse from Virus Challenge (CDC Ref. 
 I-001-01/0), U.S. Patent SN: 09/826,115
Monoclonal Antibodies against Fungi and Methods for Their Use (CDC Ref. 
 I-002-01/0), U.S. Patent SN 60/311,458
Work Force Information Zone--Web Portal (CDC Ref. : I-004-01/
0)
Isocyanate Derivatizing Agent and Methods of Production and Use (CDC 
Ref. : I-005-97/1), U.S. Patent SN:09/700,155
Multicoupon Biofilm CFSTR (CDC Ref. : I-006-01/0)
Wearable Kneel-Sit Support Device (CDC Ref. : I-007-01/0), 
U.S. Patent SN: 60/300,315
Colorimetric Artemisinin and Artemisinin Derivatives Assay and Assay 
Kit (CDC Ref. : I-008-01/0), U.S. Patent SN: 60/334,387
Methods for the Prevention and Treatment of Diseases Caused by an 
Inflammatory Response (CDC Ref. : I-009-98/1), U.S. Patent SN: 
09/889,317
Quartz Application Package (QUARTZ-PACK) (CDC Ref. : I-010-01/
0)
Pulse-field Gel Electrophoresis (PFGE) Pattern from Two Salmonella 
Branderup Strains (CDC Ref. : I-011-01/0)
Radio Frequency Safety System to Protect Workers from Caught-In Injury 
(CDC Ref. : I-014-01/0)
DNA Expression Vectors and Methods of Use (CDC Ref. : I-015-
01/0), PCT/US01/06795
Anti-sense Oligonucleotide Silencing Technique to Prevent beryllium 
Sensitization and Disease (CDC Ref. : I-016-01/0)
Method and Apparatus for Load Rate Monitoring (CDC Ref. : I-
016-98/1), U.S. Patent SN: 09/673,599
Rock Bolt with Strain Detection and Compact Data Logger (CDC Ref. 
: I-017-01/0)
Mobile Load Handling Apparatus (CDC Ref. : I-018-01/0)
Methods and Reagents for Molecular Detection of HIV-1 Groups M, N and O 
(CDC Ref. : I-020-98/1)
sigE-induced Mycobacterium tuberculosis Vaccine (CDC Ref. : I-
024-01/0)
Sup T-1 Derived Cell Lines Which Affect the HIV Life Cycle from Normal 
Sup T-1 cells (CDC Ref. : I-025-01/0)
Macroaggregated Albumin-Polyethyleneimine (MAA-PEI) Lung-Targeted 
Delivery of RSV DNA Vaccines (CDC Ref. : I-026-01/0)
The Submicrometer Aerosol Monitor (SAM) (CDC Ref. : I-027-01/0 
[combined under I-033-01/0])
The Development of DNA Probes for the Identification and Diagnosis of 
Infections Caused by Dimorphic Fungi (CDC Ref. : I-030-01/0)
An Electric Power Line Contact Alarm for Mobile Equipment (CDC Ref. 
: I-032-01/0)
The Combination Respirable Dust and Sub-micrometer Particle Monitor 
(CDC Ref. : I-033-01/0 (combined with I-027-01/0 under I-033-
01/0))
Recombinant P37/FlaA As a Diagnostic Reagent (CDC Ref. : I-
046-00/0)
Recombinant P37/FlaA as a Diagnostic Reagent (CDC Ref. : I-
046-00/1)

    Dated: June 12, 2002.
James D. Seligman,
Associate Director for Program Services, Centers for Disease Control 
and Prevention (CDC).
[FR Doc. 02-15542 Filed 6-19-02; 8:45 am]
BILLING CODE 4163-18-P